{"id":"W4364354038","doi":"10.1093/eurheartj/ehad200","title":"Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation","year":2023,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; McMaster University; Population Health Research Institute","funders":"National Institute of Neurological Disorders and Stroke; National Heart, Lung, and Blood Institute; National Institute on Aging; Uppsala Universitet; Akademiska Sjukhuset; Schweizerische Herzstiftung; Novo Nordisk; Hjärt-Lungfonden; Eisai; Svenska Sällskapet för Medicinsk Forskning; Sanofi; Abiomed; Daiichi-Sankyo; Zora Biosciences; Medicines Company; Intarcia Therapeutics; National Institutes of Health; Regeneron Pharmaceuticals; Boston Scientific Corporation; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Alexion Pharmaceuticals; Brigham and Women's Hospital; Bayer HealthCare; GlaxoSmithKline; Daiichi Sankyo Europe; Servier; Bayer; AstraZeneca; Eli Lilly and Company; Samsung; Bristol-Myers Squibb; Heart and Stroke Foundation of Canada; Pfizer; Boehringer Ingelheim; Amgen; Medtronic; National Science Foundation","keywords":"Medicine; Atrial fibrillation; Stroke (engine); Cardiology; Ischemic stroke; Internal medicine; Ischemia","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003631037,0.00009643988,0.000230167,0.0002068309,0.00009219146,0.0000305594,0.00002442143,0.00001941187,0.00006060015],"category_scores_gemma":[0.0001136231,0.00006773671,0.0001070838,0.0001661512,0.00002658613,0.0001259986,0.00002866053,0.00009510709,0.00006005655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000148288,"about_ca_system_score_gemma":0.00001423403,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":8.414895e-7,"about_ca_topic_score_gemma":2.58759e-7,"domain_scores_codex":[0.9990683,0.00009054026,0.0002563976,0.0001122802,0.0003455274,0.0001269842],"domain_scores_gemma":[0.999509,0.00008480668,0.000147061,0.00009996245,0.00008157903,0.00007753434],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003913281,0.00000218964,0.9938228,0.00001297799,0.00007121386,0.00000482618,0.00005505254,0.000344238,0.0002021526,0.00002089976,0.002096735,0.002975546],"study_design_scores_gemma":[0.00276569,0.0003759942,0.9768788,0.00004034638,0.00007354228,0.000005862792,0.00002442131,0.0002187303,0.00006125402,0.000003783059,0.01948407,0.0000675004],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996808,0.00001784365,0.00003919588,0.001057526,0.000199091,0.0001973411,0.0000057285,0.00004264796,0.001632639],"genre_scores_gemma":[0.9976916,0.00002478147,0.0004026965,0.00005637248,0.000666683,1.950551e-8,0.00003299177,0.00002200799,0.001102896],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01738734,"threshold_uncertainty_score":0.2762223,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07590535300399365,"score_gpt":0.3260823490827978,"score_spread":0.2501769960788041,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}